生物制药研发阶段的公司,暂时只谈技术,不讲财务。
summary:短中期趋势为牛市,长期趋势目前需等待突破价格$8.12后可确认为牛市,入场中期持有,6个月后检验。
短期趋势 Bullish
中期趋势 Bullish
长期趋势 待定/偏牛市
利益披露:持有PGN...查看全文
美股医药Z博士2017-12-15 05:21
$普罗基尼克斯制药(PGNX)$ 公司已有药物上市,最近主要侧重的一款药物AZEDRA针对一种比较罕见的嗜铬细胞瘤,已经获得FDA的突破性进展、快速通道以及孤儿药称号。今年8月底公司公布了该药的II期临床数据,虽然单次治疗组的效果不明显,双剂量组的治疗效果达到预期目标。同时,因为生产线的原因,公...查看全文
$普罗基尼克斯制药(PGNX)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001193125-20-185879 Act: 34 Size: 10 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013681 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013671 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013672 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013673 Size: 17 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013674 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013675 Size: 13 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013676 Size: 9 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013677 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013678 Size: 32 KB 网页链接